ATARA BIOTHERAPEUTICS, INC.
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Mar 2022 | $-84.5M | $-87.1M | $2.6M | $14.3M |
| Jun 2022 | $-64.0M | $-65.4M | $1.4M | — |
| Sep 2022 | $-65.1M | $-65.2M | $132.0K | — |
| Mar 2023 | $-38.4M | $-38.8M | $399.0K | $11.8M |
| Jun 2023 | $-52.8M | $-53.3M | $499.0K | — |
| Sep 2023 | $-51.3M | $-51.6M | $281.0K | — |
| Mar 2024 | $-29.6M | $-29.7M | $127.0K | $8.4M |
| Jun 2024 | $-10.6M | $-10.7M | $29.0K | — |
| Sep 2024 | $-4.0M | $-4.0M | $0 | — |
| Mar 2025 | $-28.1M | $-28.1M | $0 | $4.2M |
| Jun 2025 | $-7.3M | $-7.3M | $0 | — |
| Sep 2025 | $-9.8M | $-9.8M | $0 | — |
| Mar 2026 | $-3.1M | $-3.1M | — | $749.0K |
| Jun 2026 | $-3.3M | $-3.3M | — | — |